Autopsy report · NCT00791336

Study to Evaluate Using Nelfinavir With Chemoradiation for Non-small Cell Lung Cancer

“Poor enrollment.”

The sponsor’s own words in the registry.

Life of this trial

• Registered 3 months after it had already started.
• Ran for about 2 years 7 months before it stopped.
• 1 participant enrolled.
• Results were posted on the registry 6 years 4 months after it ended.

Vital statistics

Status

Terminated

Phase

Phase 2

Sponsor

University of Iowa

Sponsor type

University, hospital or other

Conditions

Carcinoma, Non-Small-Cell Lung

Interventions

Nelfinavir

Participants

1

Sites

1

Countries

United States

Trials that died the same way

• Use of Prokinetics in Early Enteral Feeding in Preterm Infants
  “very poor enrollment” (92% match in meaning)
• Reach Home and Read
  “Low enrollment.” (91% match in meaning)
• Effect of Vorinostat on ACTH Producing Pituitary Adenomas in Cushing s Disease
  “Lack of enrollment.” (86% match in meaning)
• Assessing Dynamic Magnetic Resonance (MR) Imaging in Patients With Recurrent High Grade Glioma Receiving Chemotherapy
  “Inadequate enrollment” (86% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.